Adam Wisher← All work

Project №6 · Healthcare · Marketplace · NDA

Prescription Medication Sales & Delivery in a Marketplace

Confidential case study

Company, marketplace, partner, and competitor names are intentionally withheld. Selected implementation details are anonymized because the project is presented under NDA/confidentiality constraints.

A full-cycle healthcare product concept for turning prescription search, verification, checkout, delivery, and repeat medication management into one digital journey.

Role
Product Manager · End-to-end ownership
Case type
Research · Validation · Launch design

The challenge

Prescription commerce is not a standard e-commerce transaction.

A user must find the exact medication, understand real availability, confirm the prescription, verify dosage and product details, select fulfillment, protect sensitive data, receive the order safely, and repeat the process when treatment continues.

The opportunity was to remove fragmentation and design one controlled journey: prescription → verification → search → comparison → checkout → delivery → repeat purchase.

Quantitative research

Start with behavior, not features.

I ran an exploratory online survey with 20 respondents who had experience buying medication and using digital services.

The sample was used for directional discovery and hypothesis generation—not as a statistically representative market study.

55%

Forgot to buy medication on time

50%

Had difficulty comparing prices

30%

Encountered out-of-stock medication

60%

Ranked complete availability as a key service factor

45%

Considered delivery speed an important factor

~25%

Had been offered an alternative medication

Family medication management

The buyer is often managing care for someone else.

~63%

of respondents had children under 18.

~42%

bought medication for older relatives.

This research signal expanded the concept from a one-person purchase flow into a medication-management system with family profiles, authorized recipients, prescription history, reminders, and fast repeat ordering.

Core audiences

Four recurring contexts shaped the product.

01

Chronic patients

Need reliable repeat access to the same prescribed medication without interrupting therapy.

02

Busy professionals

Want to avoid visiting multiple pharmacies and reduce the time spent completing a prescription purchase.

03

Parents & caregivers

Manage prescriptions and purchases for children, older relatives, or several family members.

04

Limited-mobility users

Need a safe and predictable way to receive medication without a physically difficult pharmacy visit.

Jobs-to-be-Done

Translate demographics into real jobs.

01

When a doctor prescribes medication

I want to verify the prescription and order online so I do not need to search across multiple pharmacies.

02

When a regular medication is running out

I want to see availability and delivery timing quickly so I can avoid interrupting treatment.

03

When I buy medication for a relative

I want to place the order remotely so I can manage care without an additional trip.

Qualitative research

A research plan built around past behavior.

I designed a 3–6 user interview program for people with previous online medication or delivery experience. The guide followed the real journey: context → search → prescription → selection → checkout → payment → waiting → receiving → problems → repeat order.

Prescription friction
Trust & privacy
Delivery uncertainty
Errors & substitutions
Human support
Repeat purchase
Family scenarios
Status transparency

Market sizing

Model the opportunity before building it.

TAM

~80.5B

Modeled annual medication market for the broad target urban audience.

SAM

~16.6B

Modeled serviceable market based on online purchasing penetration.

SOM

~8.3B

Modeled obtainable scope constrained by product resources and launch assumptions.

Product strategy

From delivery feature to medication-management experience.

Competitive research showed a gap in connecting prescription verification, live availability, checkout, fulfillment, family management, and repeat purchase in one coherent flow.

01

Search by medication, active ingredient, and dosage

02

Real-time availability and price visibility

03

Prescription upload and verification

04

Delivery or pickup selection

05

Online payment and order tracking

06

Secure recipient verification

07

Alternative-medication approval flow

08

Family profiles and recipient management

09

Prescription and order history

10

Reminders and one-click repeat ordering

MVP → MLP → Scale

Do not automate an unvalidated behavior.

01

Concierge MVP

Validate demand

Registration, consent, search, price and availability, prescription upload, manual verification, checkout, payment, delivery/pickup, and feedback.

02

MLP

Build retention

Personal account, richer search, prescription history, order history, repeat order, family profiles, reminders, notifications, and support.

03

Target product

Automate & scale

Prescription-system integrations, pharmacy inventory integrations, OCR, automated verification, live comparison, tracking, loyalty, personalization, and AI assistance.

The Concierge MVP deliberately kept prescription verification manual. The first goal was to prove that users would trust the marketplace with the prescription journey before investing in expensive healthcare integrations and automation.

Secure handover

The last meter is part of the product.

Prescription delivery introduced a recipient-verification problem that does not exist in normal marketplace fulfillment. The concept therefore included a secure handover layer such as QR-based verification or another approved identity-control mechanism.

Alternative medications were also treated as a trust-sensitive flow: the system could explain and propose an alternative, but not silently replace the medication prescribed by the clinician.

Product analytics

Connect user behavior to business viability.

I used a learning dataset to work through cohort retention, ARPU, LTV, CAC, and ROI. These values are modeled analytical outputs, not claimed production results.

~8,992

Modeled LTV

~1,229

Average modeled ARPU

~2,857–4,357

Modeled CAC range across channels

106–215%

Modeled ROI range across channels

Experimentation

Use small tests to protect large investments.

I designed a HADI / A-B experiment model to validate expensive functionality with a limited audience before full development. In one modeled scenario, a small experiment represented roughly 5% of full development cost while protecting against a materially larger downside if the hypothesis was wrong.

Progressive rollout

10% → 30% → 50% → 70% → 99% → 100%

Monitor conversion, revenue behavior, errors, and user feedback at every stage before expanding exposure.

Business model

Transaction revenue first. Retention economics second.

The modeled monetization layer combined a transaction commission with an optional subscription layer for frequent users. Subscription benefits focused on delivery, reminders, recurring orders, and loyalty rather than replacing transaction revenue.

Year 1 modeled GMV

~16.55M

Based on modeled traffic × conversion × average order value.

3-year modeled GMV

~57.7M

A planning model for evaluating scale, not a production revenue claim.

Risk management

Healthcare trust depends on what happens when something goes wrong.

Medical & personal data

Encryption, role-based access, consent management, audit logs, and data minimization.

Prescription verification

Manual verification in the MVP, followed by controlled automation and system integration.

Wrong recipient

Identity controls, authorized recipients, and secure handover verification.

Fulfillment

Double-checks, packaging controls, temperature handling, tracking, and staff procedures.

Regulatory

Licensed partners, legal review, controlled product categories, and compliance checkpoints.

Trust & substitutions

No automatic replacement of prescribed medication; alternatives require explanation and user confirmation.

Go-to-market

Use existing intent before buying new traffic.

Because the product lived inside an existing marketplace ecosystem, the launch strategy emphasized internal discovery points: search, relevant category surfaces, contextual banners, account recommendations, push notifications, and loyalty.

The key principle was to surface prescription delivery when medication intent already existed instead of treating the feature as a generic awareness campaign.

Roadmap

Manual validation → retention → automation.

The roadmap intentionally postponed complex infrastructure until after the core user behavior was validated.

Months 1–3

Concierge MVP

Validate prescription trust, ordering behavior, and operational feasibility.

Months 4–6

MLP

Strengthen repeat use through account history, family profiles, reminders, and support.

Months 7–9

Target product

Automate prescription and inventory flows, add live comparison, personalization, and AI support.

My contribution

Full-cycle product work.

01

Problem framing and product hypothesis

02

Quantitative research and survey design

03

Qualitative interview framework and CustDev plan

04

Audience segmentation, Persona, and JTBD

05

Customer journey and UX flow

06

Market sizing and competitive analysis

07

MVP, MLP, and target-product definition

08

Product analytics, cohort analysis, and retention

09

LTV, CAC, ROI, and monetization modeling

10

A/B and HADI experiment design

11

Progressive rollout strategy

12

Risk, compliance, and secure-delivery thinking

13

Go-to-market, roadmap, and scaling strategy

Case integrity

What this case does—and does not—claim.

This project represents product research, validation, strategy, launch design, analytics practice, and business modeling for a regulated marketplace category.

Survey findings are real research outputs from the project. Financial, cohort, LTV/CAC, ROI, experiment, and GMV figures are modeling exercises used to support product decisions. A production launch of a prescription-medication marketplace is not claimed as an outcome.

Validate trust before automating complexity.
Research first. Concierge MVP next. Scale only after evidence.